Philipp Csomor

1.1k total citations
26 papers, 833 citations indexed

About

Philipp Csomor is a scholar working on Nephrology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Philipp Csomor has authored 26 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 9 papers in Pathology and Forensic Medicine and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Philipp Csomor's work include Parathyroid Disorders and Treatments (10 papers), Vitamin D Research Studies (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Philipp Csomor is often cited by papers focused on Parathyroid Disorders and Treatments (10 papers), Vitamin D Research Studies (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Philipp Csomor collaborates with scholars based in Switzerland, United States and Japan. Philipp Csomor's co-authors include Franz X. Vollenweider, Boris B. Quednow, Mark A. Geyer, Benjamin K. Yee, Joram Feldon, Dominique Holstein, J. Feldon, André Schmidt, Klaas Ε. Stephan and Erich Seifritz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

Philipp Csomor

24 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philipp Csomor Switzerland 14 302 236 176 142 142 26 833
Abigail J. Sheldrick Germany 19 122 0.4× 206 0.9× 102 0.6× 161 1.1× 212 1.5× 32 918
Ni Fan China 19 362 1.2× 170 0.7× 67 0.4× 226 1.6× 171 1.2× 49 1.2k
Yumiko Ikeda Japan 15 305 1.0× 202 0.9× 38 0.2× 133 0.9× 85 0.6× 38 860
H. Kolbe Germany 21 424 1.4× 364 1.5× 490 2.8× 181 1.3× 133 0.9× 39 1.4k
F Santangelo Italy 16 190 0.6× 199 0.8× 28 0.2× 190 1.3× 188 1.3× 49 947
Angelo B.M. Cunha Brazil 13 220 0.7× 136 0.6× 137 0.8× 93 0.7× 597 4.2× 15 1.0k
Bruno Brizard France 10 128 0.4× 94 0.4× 73 0.4× 195 1.4× 84 0.6× 22 1.0k
Francesco Giorlando Australia 12 89 0.3× 132 0.6× 99 0.6× 114 0.8× 751 5.3× 14 1.4k
V. S. Fang United States 17 230 0.8× 42 0.2× 47 0.3× 197 1.4× 178 1.3× 50 912
H. M. Brecht Germany 13 180 0.6× 194 0.8× 19 0.1× 182 1.3× 56 0.4× 26 959

Countries citing papers authored by Philipp Csomor

Since Specialization
Citations

This map shows the geographic impact of Philipp Csomor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Csomor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Csomor more than expected).

Fields of papers citing papers by Philipp Csomor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Csomor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Csomor. The network helps show where Philipp Csomor may publish in the future.

Co-authorship network of co-authors of Philipp Csomor

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Csomor. A scholar is included among the top collaborators of Philipp Csomor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Csomor. Philipp Csomor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vincenti, Flavio, Jonathan S. Bromberg, Jim Kim, et al.. (2024). The hepatocyte growth factor mimetic, ANG-3777, in kidney transplant recipients with delayed graft function: Results from a randomized phase 3 trial. American Journal of Transplantation. 24(9). 1644–1651. 2 indexed citations
2.
Ayad, Sabry, Thomas M. Beaver, David Corteville, et al.. (2024). Development of and recovery from acute kidney injury after cardiac surgery: Randomized phase 2 trial of the hepatocyte growth factor mimetic ANG-3777. Journal of Thoracic and Cardiovascular Surgery. 170(4). 1125–1132.e2. 1 indexed citations
3.
Strugnell, Stephen A., Philipp Csomor, Akhtar Ashfaq, & Charles W. Bishop. (2023). Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease. SHILAP Revista de lepidopterología. 9(3). 206–217. 6 indexed citations
4.
Bishop, Charles W., Stephen A. Strugnell, Philipp Csomor, Edelgard Kaiser, & Akhtar Ashfaq. (2022). Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism. American Journal of Nephrology. 53(6). 446–454. 10 indexed citations
5.
Germain, Michael J., George Z. Fadda, Andy Nguyen, et al.. (2022). Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients. BMC Nephrology. 23(1). 362–362. 9 indexed citations
7.
Sukul, Nidhi, Angelo Karaboyas, Philipp Csomor, et al.. (2020). Self-reported Pruritus and Clinical, Dialysis-Related, and Patient-Reported Outcomes in Hemodialysis Patients. Kidney Medicine. 3(1). 42–53.e1. 86 indexed citations
8.
9.
Liabeuf, Sophie, Keith McCullough, Eric W. Young, et al.. (2019). International variation in the management of mineral bone disorder in patients with chronic kidney disease: Results from CKDopps. Bone. 129. 115058–115058. 9 indexed citations
12.
Schmidt, André, Rosilla Bachmann, Michael Kometer, et al.. (2011). Mismatch Negativity Encoding of Prediction Errors Predicts S-ketamine-Induced Cognitive Impairments. Neuropsychopharmacology. 37(4). 865–875. 85 indexed citations
13.
Holstein, Dominique, et al.. (2010). P50 suppression, prepulse inhibition, and startle reactivity in the same patient cohort suffering from posttraumatic stress disorder. Journal of Affective Disorders. 126(1-2). 188–197. 56 indexed citations
14.
Quednow, Boris B., et al.. (2008). Sensorimotor gating and attentional set-shifting are improved by the μ-opioid receptor agonist morphine in healthy human volunteers. The International Journal of Neuropsychopharmacology. 11(5). 655–69. 27 indexed citations
15.
Csomor, Philipp, et al.. (2008). On the influence of baseline startle reactivity on the indexation of prepulse inhibition.. Behavioral Neuroscience. 122(4). 885–900. 98 indexed citations
16.
Vollenweider, Franz X., et al.. (2007). The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval. Neuropsychopharmacology. 32(9). 1876–1887. 141 indexed citations
17.
Csomor, Philipp, et al.. (2007). Haloperidol Differentially Modulates Prepulse Inhibition and P50 Suppression in Healthy Humans Stratified for Low and High Gating Levels. Neuropsychopharmacology. 33(3). 497–512. 96 indexed citations
18.
Csomor, Philipp, Benjamin K. Yee, Boris B. Quednow, et al.. (2006). The monotonic dependency of prepulse inhibition of the acoustic startle reflex on the intensity of the startle-eliciting stimulus. Behavioural Brain Research. 174(1). 143–150. 18 indexed citations
19.
Vollenweider, Franz X., et al.. (2006). Clozapine Enhances Prepulse Inhibition in Healthy Humans with Low But Not with High Prepulse Inhibition Levels. Biological Psychiatry. 60(6). 597–603. 55 indexed citations
20.
Csomor, Philipp, Franz X. Vollenweider, Joram Feldon, & Benjamin K. Yee. (2005). On the feasibility to detect and to quantify prepulse-elicited reaction in prepulse inhibition of the acoustic startle reflex in humans. Behavioural Brain Research. 162(2). 256–263. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026